marijuana stock news

Growblox Sciences, Inc. (GBLX)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue –   –   –   –  
Cost of Revenue
Gross Profit –   –   –   –  
Operating Expenses
Research Development
Selling General and Administrative 678 1,780 1,495 131
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (678) (1,780) (1,495) (131)
Income from Continuing Operations
Total Other Income/Expenses Net (0) 0 0 (559)
Earnings Before Interest And Taxes (678) (1,780) (1,495) (132)
Interest Expense 14
Income Before Tax (678) (1,780) (1,495) (146)
Income Tax Expense
Minority Interest 56 110 50
Net Income From Continuing Ops (622) (1,670) (1,445) (705)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (622) (1,670) (1,445) (705)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (622) (1,670) (1,445) (705)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

INSYS Therapeutics (INSY) Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) Oral Solution

INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) Oral Solution…

Pure Global Cannabis Inc. (PRNCF) (PURE.V) ANNOUNCES MORTGAGE FINANCING AND NON-BROKERED PRIVATE PLACEMENT

PURE GLOBAL ANNOUNCES MORTGAGE FINANCING AND NON-BROKERED PRIVATE PLACEMENT   Pure Global…

 Stillcanna Inc. (STIL) (SCNNF) Continues to Refine the Future

Stillcanna Continues to Refine the Future  Stillcanna Inc. (OTC PINK:SCNNF) (STIL.CN) (FSE:A2PEWA)…

AbbVie Inc. (ABBV) and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19

AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19…